~~<i id='A2094A62CC'><strike id='A2094A62CC'><tt id='A2094A62CC'><pre id='A2094A62CC'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

explore

author：comprehensive 2025-10-01 11:46:51 - browse：73329

ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

Arch declined to comment on the new fundraising.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： Stop the failed accountable care organization experiment

entertainment

Wikipedia

explore

leisure time

focus

hotspot

JuliaRendleman/GettyImagesforEventiveMarketingHealthinsurerCignaispayingmorethan$172milliontosettlea

WSS

Why do women spend more than men on medical expenses?

Biogen shutters digital health group, ends Apple study, in cost cutting move

U.K. not yet recommending Vertex's CRISPR therapy for sickle cell

Did you have Obamacare on your GOP debate bingo card?

Researchers use wearables data and AI to predict preterm birth risk

I was wrong about Geron's blood cancer drug. Now, is it a takeover target?

hotspot

explore

entertainment

Dobbs anniversary: the lost opportunity of abortion as health care

Menendez indictment could see pharma lose a key ally

Peter Hotez and the public health issue of online harassment

Menendez indictment could see pharma lose a key ally

Moonlake's readout produced a cash windfall. Risks remain

Would Medicare drug price negotiations stall in a shutdown?

Apple is now the first public company to be valued at $3 trillion

Shingles, which affected Dianne Feinstein, is on the rise

United colonoscopy coverage change 'may cost lives,' doctors say

Mindstrong's demise and the future of mental health care

Wikipedia

Covid vaccines: Private market messier than government rollout

Plastic surgeons increase patient psychiatric screenings

AstraZeneca to buy developer of next

Physicians and social media: If you see something, say something?

Future doctors should be trained to promote social change

STAT Virtual Event: How to Increase Diversity in Clinical Trials

explore

leisure time

focus

hotspot